OTHER INFORMATION
−Removed: 10.1 Purchase and Sale Agreement, dated January 29, 2021, by and between Krystal Biotech, Inc.
−Removed: and Northfield I, LLC (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, as filed with the SEC on February 2, 2021).
+Added: 10.1 Standard Form of Contract for Construction and the corresponding General Conditions of the Contract for Construction with The Whiting-Turner Contracting Company
31.1 Certification of Periodic Report by Chief Executive Officer under Section 302 of the Sarbanes-Oxley Act of 2002.
2 unchanged sentences
Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
−Removed: 101.INS XBRL Instance Document
−Removed: 101.SCH XBRL Taxonomy Extension Schema Document
−Removed: 101.CAL XBRL Taxonomy Extension Calculation Linkbase Document
−Removed: 101.DEF XBRL Taxonomy Extension Definition Linkbase Document
−Removed: 101.LAB XBRL Taxonomy Extension Label Linkbase Document
−Removed: 101.PRE XBRL Taxonomy Extension Presentation Linkbase Document
+Added: 101 Inline XBRL (Extensible Business Reporting Language).
+Added: The following materials from this Quarterly Report on Form 10-Q for the periods ended June 30, 2021, formatted in Inline XBRL:
+Added: (i) consolidated balance sheets of Krystal Biotech, Inc., (ii) consolidated statements of operations of Krystal Biotech, Inc., (iii) consolidated statements of comprehensive income/(loss) of Krystal Biotech, Inc., (iv) consolidated statements of changes in equity of Krystal Biotech, Inc., (v) consolidated statements of cash flows of Krystal Biotech, Inc.
+Added: and (vi) notes to consolidated financial statements of Krystal Biotech, Inc.
+Added: The instance document does not appear in the interactive data file because its XBRL tags are embedded within the Inline XBRL document
+Added: 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
KRYSTAL BIOTECH, INC.
−Removed: May 10, 2021 By:
+Added: August 9, 2021 By:
President and Chief Executive Officer
4 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.